# Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC

> **NCT07080944** · NA · RECRUITING · sponsor: **European Institute of Oncology** · enrollment: 75 (estimated)

## Conditions studied

- Invasive Breast Carcinoma
- Sentinel Lymph Node Biopsy (SLNB)
- Neoadjuvant Chemotherapy

## Interventions

- **PROCEDURE:** SLN identification using technetium-99m
- **PROCEDURE:** SLN intra-operatory identification with radioguided surgery
- **PROCEDURE:** Axillary Limph Node Dissection (ALND)

## Key facts

- **NCT ID:** NCT07080944
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-12
- **Primary completion:** 2030-07
- **Final completion:** 2030-08
- **Target enrollment:** 75 (ESTIMATED)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07080944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07080944, "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07080944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*